ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,504Medicare Part D Prescriptions Filled, Including Refills

Rank: 597 out of 4623

$716K Total Retail Price of All Prescriptions

Rank: 343 out of 4623

576 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 576 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

24% of this provider’s 576 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 680 344 S3 1 3
LISINOPRIL 341 264 2 4
LEVOTHYROXINE SODIUM 334 280 3 1
AMLODIPINE BESYLATE 328 271 4 5
FUROSEMIDE 269 212 5 8
SIMVASTATIN 246 205 6 2
OMEPRAZOLE 195 149 7 7
WARFARIN SODIUM 179 147 8 24
METOPROLOL SUCCINATE 160 129 9 13
POTASSIUM CHLORIDE 160 104 9 14
CRESTOR 150 94 11 20
ZOLPIDEM TARTRATE 138 94 12 18
METOPROLOL TARTRATE 132 88 13 9
METFORMIN HCL ER 115 74 14 51
GLIMEPIRIDE 114 102 15 38
ATORVASTATIN CALCIUM 113 91 16 12
CARVEDILOL 113 102 16 25
PRAVASTATIN SODIUM 113 97 16 11
HYDROCHLOROTHIAZIDE 108 97 19 10
METFORMIN HCL 106 85 20 6
CYCLOBENZAPRINE HCL 106 38 R 20 53
SERTRALINE HCL 105 89 22 26
DIOVAN 105 96 22 39
LOSARTAN POTASSIUM 94 73 24 21
GABAPENTIN 92 46 25 16
ATENOLOL 89 70 26 28
BYSTOLIC 84 68 27 115
ROPINIROLE HCL 84 52 27 108
CLOPIDOGREL 81 67 29 31
NEXIUM 81 45 29 17
CITALOPRAM HBR 81 70 29 23
FENOFIBRATE 80 47 32 54
DIGOXIN 78 67 33 58
ALENDRONATE SODIUM 75 42 34 22
TAMSULOSIN HCL 71 67 35 29
PLAVIX 69 55 36 45
SPIRIVA 69 59 36 79
FLUTICASONE PROPIONATE 64 38 38 32
ISOSORBIDE MONONITRATE ER 63 38 39 60
SINGULAIR 58 39 40 83
ADVAIR DISKUS 57 43 41 62
TRAMADOL HCL 57 37 41 15
VESICARE 52 52 43 166
CARISOPRODOL 51 30 R 44 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.